209 related articles for article (PubMed ID: 18027216)
1. Adaptive designs for dose-finding studies based on sigmoid Emax model.
Dragalin V; Hsuan F; Padmanabhan SK
J Biopharm Stat; 2007; 17(6):1051-70. PubMed ID: 18027216
[TBL] [Abstract][Full Text] [Related]
2. Dose finding designs for continuous responses and binary utility.
Fedorov VV; Wu Y
J Biopharm Stat; 2007; 17(6):1085-96. PubMed ID: 18027218
[TBL] [Abstract][Full Text] [Related]
3. Adaptive Dc-optimal designs for dose finding based on a continuous efficacy endpoint.
Padmanabhan SK; Dragalin V
Biom J; 2010 Dec; 52(6):836-52. PubMed ID: 20891026
[TBL] [Abstract][Full Text] [Related]
4. A hybrid Bayesian adaptive design for dose response trials.
Chang M; Chow SC
J Biopharm Stat; 2005; 15(4):677-91. PubMed ID: 16022172
[TBL] [Abstract][Full Text] [Related]
5. On the efficiency of two-stage response-adaptive designs.
Dette H; Bornkamp B; Bretz F
Stat Med; 2013 May; 32(10):1646-60. PubMed ID: 22865374
[TBL] [Abstract][Full Text] [Related]
6. Hypothesis testing and Bayesian estimation using a sigmoid Emax model applied to sparse dose-response designs.
Thomas N
J Biopharm Stat; 2006; 16(5):657-77. PubMed ID: 17037264
[TBL] [Abstract][Full Text] [Related]
7. Optimal design for dose response using beta distributed responses.
Wu Y; Fedorov VV; Propert KJ
J Biopharm Stat; 2005; 15(5):753-71. PubMed ID: 16078383
[TBL] [Abstract][Full Text] [Related]
8. Optimal designs for estimating the interesting part of a dose-effect curve.
Miller F; Guilbaud O; Dette H
J Biopharm Stat; 2007; 17(6):1097-115. PubMed ID: 18027219
[TBL] [Abstract][Full Text] [Related]
9. Optimal adaptive design in clinical drug development: a simulation example.
Maloney A; Karlsson MO; Simonsson US
J Clin Pharmacol; 2007 Oct; 47(10):1231-43. PubMed ID: 17906158
[TBL] [Abstract][Full Text] [Related]
10. Adaptive designs for dose-finding in non-cancer phase II trials: influence of early unexpected outcomes.
Resche-Rigon M; Zohar S; Chevret S
Clin Trials; 2008; 5(6):595-606. PubMed ID: 19029208
[TBL] [Abstract][Full Text] [Related]
11. Design of multi-centre trials with binary response.
Dragalin V; Fedorov V
Stat Med; 2006 Aug; 25(16):2701-19. PubMed ID: 16252268
[TBL] [Abstract][Full Text] [Related]
12. An adaptive dose-finding design incorporating both toxicity and efficacy.
Zhang W; Sargent DJ; Mandrekar S
Stat Med; 2006 Jul; 25(14):2365-83. PubMed ID: 16220478
[TBL] [Abstract][Full Text] [Related]
13. Bayesian optimal adaptive designs for delayed-response dose-finding studies.
Li W; Fu H
J Biopharm Stat; 2011 Sep; 21(5):888-901. PubMed ID: 21830921
[TBL] [Abstract][Full Text] [Related]
14. Sequential designs for logistic phase I clinical trials.
Liu G; Rosenberger WF; Haines LM
J Biopharm Stat; 2006; 16(5):605-21. PubMed ID: 17037261
[TBL] [Abstract][Full Text] [Related]
15. Sample size calculation for the Power Model for dose proportionality studies.
Sethuraman VS; Leonov S; Squassante L; Mitchell TR; Hale MD
Pharm Stat; 2007; 6(1):35-41. PubMed ID: 17323313
[TBL] [Abstract][Full Text] [Related]
16. Optimal dose-finding designs with correlated continuous and discrete responses.
Fedorov V; Wu Y; Zhang R
Stat Med; 2012 Feb; 31(3):217-34. PubMed ID: 22162014
[TBL] [Abstract][Full Text] [Related]
17. An adaptive optimal design for the E(max) model and its application in clinical trials.
Leonov S; Miller S
J Biopharm Stat; 2009; 19(2):360-85. PubMed ID: 19212886
[TBL] [Abstract][Full Text] [Related]
18. Viewpoints on the FDA draft adaptive designs guidance from the PhRMA working group.
Gallo P; Anderson K; Chuang-Stein C; Dragalin V; Gaydos B; Krams M; Pinheiro J
J Biopharm Stat; 2010 Nov; 20(6):1115-24. PubMed ID: 21058107
[TBL] [Abstract][Full Text] [Related]
19. A comparison of adaptive allocation rules for group-sequential binary response clinical trials.
Morgan CC; Stephen Coad D
Stat Med; 2007 Apr; 26(9):1937-54. PubMed ID: 16981177
[TBL] [Abstract][Full Text] [Related]
20. Innovative approaches for designing and analyzing adaptive dose-ranging trials.
Bornkamp B; Bretz F; Dmitrienko A; Enas G; Gaydos B; Hsu CH; König F; Krams M; Liu Q; Neuenschwander B; Parke T; Pinheiro J; Roy A; Sax R; Shen F
J Biopharm Stat; 2007; 17(6):965-95. PubMed ID: 18027208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
